Business
Notice of Results
Notice of Results.
About this update from Advanced Medical Solutions Group Plc
[{"type":"text","content":"\n \n \n 14 February 2023\n \n \n \n \n \n Advanced Medical Solutions Group plc\n \n \n (\"AMS\" or the \"Group\")\n \n \n \n \n \n Notice of Preliminary Results\n \n \n \n \n \n Winsford, UK:\n Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, will announce its preliminary results for the twelve months ended 31 December 2022 on Wednesday 15 March 2023.\n \n \n \n \n \n A briefing for analysts will be held at 10am GMT on the day of the results. For further information, please contact\n \n \n [email protected]\n \n \n .\n \n \n \n \n \n \n - End -\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n For further information, please contact:\n \n \n \n \n \n \n \n \n \n \n \n Advanced Medical Solutions Group plc\n \n \n \n \n \n Tel: +44 (0) 1606 545508\n \n \n \n \n \n \n Chris Meredith, Chief Executive Officer\n \n \n Eddie Johnson, Chief Financial Officer\n \n \n Michael King, Investor Relations\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Consilium Strategic Communications\n \n \n \n \n \n Tel: +44 (0) 20 3709 5700\n \n \n \n \n \n \n Matthew Neal /\n Lucy Featherstone\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Investec Bank PLC (NOMAD & Broker)\n \n \n \n \n \n Tel: +44 (0) 20 7597 5970\n \n \n \n \n \n \n Gary Clarence/ David Anderson\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n HSBC Bank PLC (Broker)\n \n \n \n \n \n Tel: +44 (0) 20 7991 8888\n \n \n \n \n \n \n Sam McLennan / Joe Weaving / Stephanie Cornish\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n About Advanced Medical Solutions Group plc\n \n \n \n AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8® and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label...